Hewlett-Packard's medical sales regain vigour
This article was originally published in Clinica
After a flat 1994 for Hewlett-Packard's medical electronics sales, the first half of fiscal 1995 has seen renewed revenue growth in a division lagging the otherwise strongly-performing US electronics company. Medical electronics sales in the first quarter grew 15% to $328 million and 12% to $634 million in the first half.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.